Rapid Micro Biosystems (RPID) Debt Ratio (2020 - 2026)
Rapid Micro Biosystems (RPID) posted Debt Ratio of 0.31 for Q1 2026, up 20.99% sequentially from 0.25 in Q4 2025.
Rapid Micro Biosystems (RPID) Debt Ratio (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems has reported Debt Ratio for 4 years, with the latest figure at 0.31 in Q1 2026.
- Quarterly Debt Ratio changed N/A year-over-year to 0.31 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.31 (changed N/A YoY) and the FY2025 annual result came in at 0.25, changed N/A from the prior year.
- Debt Ratio advanced to 0.31 in Q1 2026 per RPID's latest filing, from 0.25 in the prior quarter.
- Over five years, Debt Ratio peaked at 0.31 in Q1 2026 and troughed at 0.22 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 0.30 |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 0.31 |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 0.30 |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 0.28 |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 0.04 |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 0.27 |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 0.28 |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 0.18 |
| 10 | Rapid Micro Biosystems | 82.91 Mn | 63.15 Mn | 1.21 Mn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.33 |
| Mar 31, 2026 | 0.31 |
| Dec 31, 2025 | 0.25 |
| Sep 30, 2025 | 0.22 |
| Jun 30, 2021 | 0.19 |
| Dec 31, 2020 | 0.35 |